Senior insider sale
Chief Legal Officer at TSCAN THERAPEUTICS, INC. — senior position signals high conviction
$905.8K
164.69K shares
What this filing means
ZDRAVESKI ZORAN plans to sell 164.69K shares of TSCAN THERAPEUTICS, INC. valued at approximately $905.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/23/2024ACC: 0001972362-24-001224
Officer· Chief Legal Officer
Since Sep 2021
164.69K
Shares to sell
$905.8K
Approx. market value
164.69K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
STOCK OPTION EXERCISE
COMPENSATION
8/23/2024
157.19KESPP
COMPENSATION
12/31/2022
7.50KTotal acquired164.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/23/2024 | STOCK OPTION EXERCISE COMPENSATION | 157.19K | — |
12/31/2022 | ESPP COMPENSATION | 7.50K | — |
| Total | 164.69K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
164.69K
Market value
$905.8K
8/23/2024
Total
Units
164.69K
Value
$905.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/23/2024 | 164.69K | $905.8K | NASDAQ | Planned |
| Total | 164.69K | $905.8K | ||